Menu

Protein Prep 101 - Extracting Value

Learn about common challenges to protein preparation protocols, typical protein isolation workflows, considerations when working with challenging samples, and how to confirm intact protein extraction with this eBook!

May 9, 2018
The Scientist Creative Services Team

If DNA is the blueprint of life, then proteins comprise the edifices themselves. Naturally, the study of proteins – their structures, abundance, function, and interactions – has proven integral to our understanding of biology. Protein-centered research is pivotal to human health and disease, and protein-based products are consumed commercially, used in academic research, and serve as biopharmaceuticals.

To effectively study proteins or manufacture protein-based products, researchers need to be able to detect, characterize, and quantify the protein(s) of interest. The actual steps involved in protein extraction and preparation protocols will depend on a host of factors, but all protein preparation protocols strive to optimize two main parameters: yield and purity.

Download this eBook from The Scientist and MilliporeSigma to learn about:
 • Common challenges to protein preparation protocols
 • A typical protein isolation workflow
 • Considerations when working with challenging samples
 • Confirming intact protein extraction

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.